Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00814970 · ClinicalTrials.gov registry record · NA
The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions
A NA study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 196
- Enrollment target
NCT00814970 is a NA study that has completed, run by Medtronic Endovascular. The registered enrollment target is 196 participants.
The verdict
NCT00814970, a NA study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 196 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of the Complete SE SFA Stent System in the treatment of de novo and/or restenotic lesions or occlusions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) in subjects with symptomatic Peripheral Artery Disease (PAD).
Interventions
- DEVICE Complete SE Vascular Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2008-11 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00814970
The ClinicalTrials.gov registry entry for NCT00814970 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Complete SE Vascular Stent System is the first listed.
NCT00814970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00814970 about?
NCT00814970 is a clinical study titled "The Complete® SE SFA Study for the Treatment of SFA/PPA Lesions". To evaluate the safety and efficacy of the Complete SE SFA Stent System in the treatment of de novo and/or restenotic lesions or occlusions in the Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) in subjects with symptomatic Peripheral Artery Disease (PAD).
What is the current status of trial NCT00814970?
This trial is currently completed. It is a NA study. The enrollment target is 196 participants. The study started on 2008-11. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00814970?
The interventions under investigation include: Complete SE Vascular Stent System (DEVICE).
Who is sponsoring clinical trial NCT00814970?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.